Compumedics Limited (ASX:CMP)
Australia · Delayed Price · Currency is AUD 0.2250
-0.0100 (-4.26%)
Aug 7, 2026, 1:27 PM AEST
Compumedics Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 58.49 | 51.04 | 50.26 | 42.92 | 38.61 | 35.74 |
Revenue Growth | 14.60% | 1.55% | 17.10% | 11.18% | 8.02% | 1.91% |
Gross Profit Gross Profit Growth | 31.24 | 28.13 | 26.61 | 22.11 | 20.17 | 19.16 |
Operating Income Operating Income Growth | 3.06 | 0.9 | -0.27 | -3.02 | 0.99 | 0.96 |
Net Income Net Income Growth | 0.11 | -1.27 | -0.34 | -6.12 | 1.36 | 1 |
Earnings Per Share EPS Growth | 0.00 | -0.01 | -0.00 | -0.03 | 0.01 | 0.01 |
EPS Growth | - | - | - | - | 35.97% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Inter-Segment Elimination Inter-Segment Elimination Growth | -15.3 | -11.68 | -7.66 | -6.43 | -9.45 | -7.79 |
Australia and Asia Pacific Australia and Asia Pacific Growth | 38.45 | 31.3 | 35.84 | 23.56 | 20.64 | 18.92 |
Americas Americas Growth | - | 18.18 | 10.95 | 12.51 | 12.67 | 11.25 |
Europe & The Middle East Europe & The Middle East Growth | - | 13.03 | 10.59 | 12.77 | 13.89 | 13.36 |
Total Total Growth | 58.28 | 50.83 | 49.72 | 42.41 | 37.76 | 35.74 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 2 | 2.69 | 1.89 | 3.8 | 7.29 | 6.77 |
Total Debt Total Debt Growth | 13.4 | 13.88 | 8.58 | 9.47 | 6.55 | 5.82 |
Net Cash (Debt) Net Cash Growth | -11.39 | -11.19 | -6.69 | -5.67 | 0.75 | 0.95 |
Net Cash Growth | - | - | - | - | -21.47% | -41.10% |
Net Cash Per Share Net Cash Per Share Growth | -0.05 | -0.06 | -0.04 | -0.03 | 0.00 | 0.01 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 4.37 | 0.45 | 2 | 0.05 | 3.29 | 1.32 |
Capital Expenditures CapEx Growth | -0.04 | -0.21 | -0.31 | -0.92 | -0.62 | -0.16 |
Free Cash Flow Free Cash Flow Growth | 4.33 | 0.23 | 1.69 | -0.88 | 2.67 | 1.16 |
Free Cash Flow Growth | 1757.51% | -86.20% | - | - | 130.06% | -76.68% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 53.42% | 55.11% | 52.94% | 51.50% | 52.25% | 53.62% |
Operating Margin | 5.24% | 1.75% | -0.53% | -7.03% | 2.56% | 2.68% |
Pretax Margin | 2.89% | -0.81% | 0.95% | -15.65% | 4.40% | 2.17% |
Profit Margin | 0.19% | -2.48% | -0.67% | -14.26% | 3.52% | 2.79% |
FCF Margin | 7.40% | 0.46% | 3.36% | -2.04% | 6.92% | 3.25% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 8, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 397.76 | - | - | - | 20.24 | 70.12 |
Forward PE | 15.00 | 11.59 | 11.41 | 11.41 | 11.41 | 12.54 |
P/FCF Ratio | 10.39 | 210.17 | 35.16 | - | 10.28 | 60.28 |
PS Ratio | 0.77 | 0.96 | 1.18 | 0.74 | 0.71 | 1.96 |